Multiple Myeloma
Talizer Thalidomide + Wiserdex Dexamethasone is indicated as a first line therapy for patients recently diagnosed with multiple myeloma.

• Recommended use by American Society of Hematologist (ASH)
• Approved use by FDA 2005 ¹
• New hope for the future of multiple myeloma as a malignant disease.
  
  Indicated as maintenance therapy, recently diagnosed treatment, prevention of recurrence.

Leprosy Reaction

Talizer Thalidomide is the treatment of choice in the reaction type II of leprosy known as (erythema nodosum leprosum) ENL
The association with neuritis in 56.4% of moderate and severe cases of ENL required the co-intervention with steroids.

• Approved by WHO in 1967 ¹
• Approved by FDA in 1998 ¹

¹ NOTE: The use of Thalidomide has been approved for specific uses as indicated where previously Thalidomide was banned worldwide, however, Serral has sold Talizer in large quantities under special access and local approvals and is in the process of obtaining EMEA approval.